REG - Uniphar PLC - Acquisition of healthcare agency Inspired Health

UnipharAnnouncement

04/10/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221004:nRSD6008Ba&default-theme=true

RNS Number : 6008B  Uniphar PLC  04 October 2022

Uniphar plc today announces the acquisition of US healthcare agency Inspired
Health

 

Dublin, London | 04 October 2022: Uniphar plc (the "Group") today announces
the acquisition of Boston, MA headquartered Inspired Health ("Inspired").

Inspired is a healthcare insights and intelligence consultancy. Using
innovative market research techniques, Inspired assists its life science
clients to better understand physicians, patients, administrators, and payers.
These insights are leveraged to assist clients optimise product innovation and
commercialise their assets.

High quality research and insights are the foundation to a successful
commercialisation strategy. Inspired Health will be integrated into Uniphar's
Commercial & Clinical division. Inspired's market research expertise will
enable Uniphar to evolve its commercialisation offering to enhance its
clients' competitiveness and improve healthcare delivery.

The acquisition increases Uniphar's presence in the strategically important US
market and Inspired will complement our recent US acquisitions of BESTMSLs,
Diligent Health Solutions and RRD International.

The purchase price includes an upfront payment plus contingent consideration
payable upon future financial performance. The founders recognise the enhanced
opportunity to grow the business as part of Uniphar Group and remain fully
engaged as a core part of the business going forward.

The acquisition is expected to deliver a Return on Capital Employed in line
with Uniphar's target rate of 12%-15% within three years.

Commenting on today's announcement

Ger Rabbette, CEO of Uniphar said:

"The acquisition of Inspired Health adds another vital component to our high
value commercialisation offering and further increases our scale in the
world's largest healthcare market. Market research is the first step on the
journey towards successful commercialisation and the insights gained from
Inspired's innovative service offering will be leveraged across the Group. We
are excited to welcome the highly innovative Inspired team to the Group."

Kieron Mathews, Senior Executive Officer of Inspired Health:

"Inspired Health has been on an incredible journey over the last number of
years and today marks a significant milestone for the team. The Uniphar Group
recognise the important role insights, data and market research play across an
asset's lifecycle and as such is an ideal home for Inspired Health. Uniphar
have built a compelling commercial offering to date, and we look forward to
adding to that through our innovative solutions."

Andrew Wilson, Senior Executive Officer of Inspired Health:

"Joining the Uniphar Group will enable the Inspired team to continue to
deliver for our existing and growing client base while benefiting from
additional opportunities as part of a larger organisation with an enhanced
service offering."

 

 

 

For further details contact:

 Uniphar                                                                      +353 (0) 1 428 7777

 Seamus Egan
 Head of Corporate Development and IR                                         investor.relations@Uniphar.ie (mailto:investor.relations@Uniphar.ie)

 Davy (Joint Corporate Broker, Nominated Adviser and Euronext Growth Listing  +353 (0) 1 679 6363
 Sponsor)
 Barry Murphy
 Niall Gilchrist
 Lauren O'Sullivan

 RBC Capital Markets (Joint Corporate Broker)                                 +44 (0) 20 7653 4000
 Jonathan Hardy
 Jamil Miah

 Stifel Nicolaus Europe Limited (Joint Corporate Broker                       +44 (0) 20 7710 7600
 Matt Blawat
 Ben Maddison
 Francis North

 Q4 PR                                                                        +353 (0) 1 475 1444 or
 (Public Relations Adviser to Uniphar)                                        +353 87 235 6461
 Iarla Mongey

About Uniphar plc

 

Headquartered in Dublin, Ireland, the Uniphar Group is an international
diversified healthcare services business servicing the requirements of more
than 200 multinational pharmaceutical and medical technology manufacturers
across three divisions - Commercial & Clinical, Product Access and Supply
Chain & Retail. The Group is active in Ireland, the UK, Europe, the US and
Australia.

The Company's vision is to improve patient access to pharmaco-medical products
and treatments by enhancing connectivity between manufacturers and healthcare
stakeholders. Uniphar represents a strong combination of scale, growth, and
profitability.

 

Commercial & Clinical

In Commercial & Clinical, the Group provides outsourced sales, marketing
& distribution solutions to multinational pharmaceutical and medical
device manufacturers. Active in Ireland, the UK, Benelux, the Nordics, Germany
and the US, the Group is growing with its clients to provide pan-European
solutions, with a targeted service offering in the US. Uniphar has built fully
integrated digitally enabled customer centric solutions that are supported by
our highly experienced and clinically trained teams, leveraging our digital
technology and insights which allows us to deliver consistently exceptional
outcomes for our clients.

 

Product Access

In Product Access, the Group is growing two distinct service offerings: 1) "On
Demand", which are pharmacy led solutions for sourcing and supplying
unlicensed medicines to meet the needs of both retail and hospital
pharmacists; and 2) "Exclusive Access", which are manufacturer led solutions
for controlling the release of speciality medicines for specifically approved
patient populations in agreed markets. The Group currently delivers product
access solutions on a global basis.

 

Supply Chain & Retail

Uniphar is an established market leader in Ireland with c. 53% market share in
the wholesale/hospital market, supported by a network of 381 owned, franchised
and symbol group pharmacies. The business supports the diverse customer base
through the provision of strong service levels coupled with innovative
commercial initiatives. Supply Chain & Retail is an Irish only business
for the Group, although the manufacturer relationships and infrastructure are
also utilised for the benefit of the Commercial & Clinical and Product
Access divisions

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACQMJBJTMTAMBPT